整合素β3失调通过破坏Rho相关蛋白激酶依赖性细胞骨架动力学损害巨核细胞生成和微粒产生
该研究探讨整合素β3及细胞骨架动力学在巨核细胞生成中的作用。体外实验显示抗β3抗体SZ21过度激活RhoA-ROCK信号,稳定F-肌动蛋白聚合,损害前血小板和巨核细胞来源微粒释放;ROCK抑制剂Y27632可逆转缺陷,并在血小板减少小鼠中加速血小板恢复而不影响止血。
要点
- 抗β3抗体SZ21过度激活RhoA-ROCK信号,稳定F-肌动蛋白聚合,损害前血小板和巨核细胞来源微粒释放。
- 巨核细胞来源微粒释放依赖肌动蛋白解聚,前血小板形成需要微管组装和肌动球蛋白收缩。
- ROCK抑制剂Y27632在体外逆转缺陷,并在血小板减少小鼠中加速血小板恢复而不影响止血。
核心结论
- 研究揭示整合素β3-ROCK轴在免疫介导的巨核细胞功能障碍中的新失调机制,靶向ROCK信号或细胞骨架动力学可能是血小板减少症及其他影响血小板产生的疾病的有前景的治疗策略。
研究设计与样本
- 在整合素β3受体受损环境下,于体内和体外评估前血小板形成和巨核细胞来源微粒释放,并分析整合素活化及RhoA相关激酶触发的信号。
主要发现
- 在人巨核细胞培养中,抗β3抗体SZ21过度激活RhoA-Rho相关蛋白激酶(ROCK)信号,通过LIM激酶/肌球蛋白轻链2磷酸化稳定F-肌动蛋白聚合,损害前血小板和巨核细胞来源微粒释放。
- 巨核细胞来源微粒释放依赖肌动蛋白解聚,而前血小板形成需要微管组装和肌动球蛋白收缩,揭示巨核细胞副产物间细胞骨架调控的差异。
- 药理学ROCK抑制(Y27632)在体外挽救这些缺陷,并在血小板减少小鼠中加速血小板恢复而不影响止血。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Megakaryocyte (MK) fragmentation into proplatelets (PPTs) and microparticles (megakaryocyte-derived microparticles [MKMPs]) is well established, yet the mechanisms underlying MKMP generation remain unclear. OBJECTIVES: This study aimed to investigate the role of integrin β3 and cytoskeletal dynamics during megakaryopoiesis and explore potential therapeutic targets for thrombocytopenia. METHODS: Proplatelet formation and MKMP release were evaluated both in vivo and in vitro under integrin β3 receptor-impaired environment. The integrin activation and RhoA-associated kinase triggered signaling were analyzed. RESULTS: In human MK cultures, we demonstrated that the anti-β3 antibody SZ21 hyperactivated RhoA‒Rho-associated protein kinase (ROCK) signaling, stabilizing F-actin polymerization via LIM kinase/myosin light chain 2 phosphorylation and impairing both PPT and MKMP release. MKMP release depends on actin depolymerization, whereas PPT formation requires microtubule assembly and actomyosin contraction, revealing differential cytoskeletal regulation among megakaryocytic byproducts. Pharmacologic ROCK inhibition with Y27632 rescued these defects in vitro and accelerated platelet recovery in thrombocytopenic mice without compromising hemostasis. CONCLUSIONS: Our study reveals a novel dysregulation of the integrin β3-ROCK axis in immune-mediated MK dysfunction and suggests that targeting ROCK signaling or cytoskeletal dynamics may represent promising therapeutic strategies for thrombocytopenia and other disorders affecting platelet production.
引用
- Wang W, Zhai J, Wang Y, et al. Integrin β3 dysregulation impairs megakaryopoiesis and microparticle production via disrupting Rho-associated protein kinase-dependent cytoskeletal dynamics. J Thromb Haemost. 2025. PMID: 40915574. doi:10.1016/j.jtha.2025.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。